Literature DB >> 4205522

A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils.

G Husby, J B Natvig.   

Abstract

A nonimmunoglobulin protein with the molecular weight of 9,145 (protein AS) has been shown to be a principal component of the amyloid fibrils in different clinical types of amyloidosis. A protein component, antigenically closely related to protein AS, was detected in human sera. The protein AS-related component (protein ASC) was found in the sera of many groups of patients, including 48 out of 55 patients with various clinical types of amyloidosis. No structural relationship of protein ASC to the plasma component of amyloid was found. Protein ASC was also present with high frequency in the serum of diseases known to be frequently complicated by amyloidosis. In some cases, ASC was found in the sera of patients 2-3 yr before the diagnosis of amyloidosis was established. Protein ASC was also frequently found in hypogammaglobulinemia. Among normal individuals, protein ASC was seldom detected in the serum by our techniques, but there was a noticeable increase with age and during pregnancy. Moreover, a more sensitive technique, immunoelectro-osmophoresis, revealed protein ASC in a higher number of sera from both patients and normal controls. Thus protein ASC was suggested to be a normal serum constituent, usually present only in minor quantities. Under certain conditions, protein ASC increases considerably in serum, and may in such instances act as a precursor for the deposition of amyloid fibrils in the tissues.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4205522      PMCID: PMC333090          DOI: 10.1172/JCI107642

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  The genesis of apudamyloid in endocrine polypeptide tumours: histochemical distinction from immunamyloid.

Authors:  A G Pearse; S W Ewen; J M Polak
Journal:  Virchows Arch B Cell Pathol       Date:  1972

Review 2.  Amyloidosis: its nature and pathogenesis.

Authors:  G G Glenner; W D Terry; C Isersky
Journal:  Semin Hematol       Date:  1973-01       Impact factor: 3.851

3.  Unique amyloid protein subunit common to different types of amyloid fibril.

Authors:  G Husby; J B Natvig; T E Michaelsen; K Sletten; H Höst
Journal:  Nature       Date:  1973-08-10       Impact factor: 49.962

4.  The acid-soluble fraction of amyloid--a fibril forming protein.

Authors:  M Pras; T Reshef
Journal:  Biochim Biophys Acta       Date:  1972-06-22

5.  Alternative, non-immunoglobulin origin of amyloid fibrils.

Authors:  G Husby; K Sletten; T E Michaelsen; J B Natvig
Journal:  Nat New Biol       Date:  1972-08-09

6.  P-component of amyloid: amino-terminal sequence.

Authors:  M Skinner; A S Cohen
Journal:  Biochem Biophys Res Commun       Date:  1973-09-18       Impact factor: 3.575

7.  The structural subunit of amyloid. Isolation and characterization of a polypeptide capable of fibril formation.

Authors:  A Zuckerberg; J Gazith; A Rimon; T Reshef; J Gafni
Journal:  Eur J Biochem       Date:  1972-07-13

8.  Creation of "amyloid" fibrils from Bence Jones proteins in vitro.

Authors:  G G Glenner; D Ein; E D Eanes; H A Bladen; W Terry; D L Page
Journal:  Science       Date:  1971-11-12       Impact factor: 47.728

9.  The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils.

Authors:  M Levin; E C Franklin; B Frangione; M Pras
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

10.  Immunologic studies of the major nonimmunoglobulin protein of amyloid. I. Identification and partial characterization of a related serum component.

Authors:  M Levin; M Pras; E C Franklin
Journal:  J Exp Med       Date:  1973-08-01       Impact factor: 14.307

View more
  43 in total

1.  Histochemical similarity of senile plaque amyloid to apudamyloid.

Authors:  J M Powers; S S Spicer
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-11-17

2.  Activities of lysosomal enzymes and levels of serum amyloid A (SAA) in blood plasma of hamsters during casein induction of AA-amyloidosis.

Authors:  P R Hol; A M van Ederen; F W Snel; J P Langeveld; J H Veerkamp; E Gruys
Journal:  Br J Exp Pathol       Date:  1985-06

3.  Serum amyloid A: evidence for its origin in polymorphonuclear leukocytes.

Authors:  C J Rosenthal; L Sullivan
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

4.  The failure of ascorbic acid therapy to alter the induction or remission of murine amyloidosis.

Authors:  M L Baltz; D Caspi; B E Glatthaar; U Moser; M B Pepys
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

5.  Serum amyloid A protein in acute viral infections.

Authors:  H Miwata; T Yamada; M Okada; T Kudo; H Kimura; T Morishima
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

6.  Amyloid fibril protein AA in Papua New Guinean amyloidosis.

Authors:  R F Anders; M A Price; I S Wilkey; G Husby; F Takitaki; J B Natvig; K P McAdam
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

7.  Serum amyloid A gene expression under acute-phase conditions involves participation of inducible C/EBP-beta and C/EBP-delta and their activation by phosphorylation.

Authors:  A Ray; B K Ray
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

8.  Reticular cell hyperplasia and amyloidosis in a line of mice with low leukocyte counts.

Authors:  C K Chai
Journal:  Am J Pathol       Date:  1976-10       Impact factor: 4.307

9.  Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation.

Authors:  K P McAdam; R J Elin; J D Sipe; S M Wolff
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

10.  Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin.

Authors:  R P Linke; J D Sipe; P S Pollock; T F Ignaczak; G G Glenner
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.